INmune Bio Ownership | Who Owns INmune Bio?

Overview Forecast RevenueFinancials Chart Transcripts

INmune Bio Ownership Summary

INmune Bio is owned by 26.06% institutional investors, 28.73% insiders, and 45.21% retail investors. Blackrock is the largest institutional shareholder, holding 4.51% of INMB shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.96% of its assets in INmune Bio shares.

INMB Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	INmune Bio	26.06%	28.73%	45.21%
Sector	Healthcare Stocks	47.06%	8.01%	44.93%
Industry	Biotech Stocks	44.97%	7.82%	47.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	812.89K	4.51%	$7.17M
Vanguard group	628.30K	3.49%	$5.54M
Cvi	596.37K	3.31%	$5.26M
Praetorian pr	485.00K	2.69%	$4.28M
Geode capital management	323.20K	1.79%	$2.85M
Raymond james financial services advisors	227.53K	1.26%	$2.01M
Rhenman & partners asset management ab	178.28K	0.99%	$1.57M
State street	167.59K	0.93%	$1.48M
Mai capital management	160.58K	0.89%	$1.42M
Marshall wace, llp	115.92K	0.64%	$1.02M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Cvi	596.37K	4.54%	$5.26M
Praetorian pr	485.00K	1.57%	$4.28M
Rhenman & partners asset management ab	178.28K	0.15%	$1.57M
Corton capital	20.55K	0.10%	$181.21K
Westside investment management	45.34K	0.09%	$399.90K
Fermata advisors	34.14K	0.07%	$301.12K
Laird norton trust company	31.50K	0.04%	$277.83K
Mai capital management	160.58K	0.01%	$1.42M
Financial advocates investment management	11.50K	0.01%	$101.43K
Raymond james financial services advisors	227.53K	0.00%	$2.01M

Top Buyers

Holder	Shares	% Assets	Change
Cvi	596.37K	4.54%	596.37K
Blackrock	812.89K	0.00%	572.73K
Praetorian pr	485.00K	1.57%	485.00K
Raymond james financial services advisors	227.53K	0.00%	227.53K
Geode capital management	323.20K	0.00%	152.40K

Top Sellers

Holder	Shares	% Assets	Change
Goldman sachs group	11.66K	-	-75.95K
Jane street group	-	-	-73.97K
Millennium management	92.67K	0.00%	-66.52K
Citigroup	2.66K	-	-45.39K
Hrt financial lp	-	-	-29.90K

New Positions

Holder	Shares	% Assets	Change	Value
Cvi	596.37K	4.54%	596.37K	$5.26M
Praetorian pr	485.00K	1.57%	485.00K	$4.28M
Raymond james financial services advisors	227.53K	0.00%	227.53K	$2.01M
Charles schwab investment management	37.27K	0.00%	37.27K	$328.77K
Corton capital	20.55K	0.10%	20.55K	$181.21K

Sold Out

Holder	Change
Fny investment advisers	-100.00
Macquarie group	-444.00
Redwood wealth management group	-2.20K
Tower research capital llc (trc)	-2.25K
Qube research	-3.38K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	65	8.33%	5,259,609	15.17%	26	4.06%	44	22.22%	8	-20.00%
Jun 30, 2024	60	11.11%	4,566,933	66.72%	25	10.88%	36	33.33%	10	-16.67%
Mar 31, 2024	54	3.85%	2,739,265	19.51%	15	9.42%	27	-3.57%	12	50.00%
Dec 31, 2023	52	26.83%	2,292,122	7.43%	12	9.00%	28	100.00%	8	-11.11%
Sep 30, 2023	41	10.81%	2,133,639	-2.40%	11	8.01%	14	-6.67%	9	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	434.27K	1.96%	-
iShares Russell 2000 ETF	310.91K	1.40%	-700.00
Rhenman Healthcare Equity L/S RC2 SEK	178.28K	0.90%	-
Vanguard Institutional Extnd Mkt Idx Tr	165.87K	0.84%	-
Fidelity Small Cap Index	125.00K	0.63%	-2.86K
iShares Russell 2000 Growth ETF	131.18K	0.59%	-
Fidelity Extended Market Index	78.73K	0.40%	1.96K
State St Russell Sm/Mid Cp® Indx NL Cl C	66.66K	0.30%	-2.80K
Vanguard Russell 2000 ETF	61.73K	0.28%	-374.00
State St Russell Sm Cap® Indx SL Cl I	60.00K	0.27%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 30, 2024	Moss David J	Chief Financial Officer	Buy	$52.87K
Sep 12, 2024	Tesi Raymond Joseph	President and CEO	Buy	$98.43K
Sep 12, 2024	Tesi Raymond Joseph	President and CEO	Buy	$98.05K
Sep 12, 2024	Moss David J	Chief Financial Officer	Buy	$49.22K
Sep 12, 2024	Moss David J	Chief Financial Officer	Buy	$49.02K

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	5	-
2024 Q2	9	-
2023 Q4	1	-
2023 Q3	-	1
2023 Q1	1	-

INMB Ownership FAQ

Who Owns INmune Bio?

INmune Bio shareholders are primarily institutional investors at 26.06%, followed by 28.73% insiders and 45.21% retail investors. The average institutional ownership in INmune Bio's industry, Biotech Stocks , is 44.97%, which INmune Bio falls below.

Who owns the most shares of INmune Bio?

INmune Bio’s largest shareholders are Blackrock (812.9K shares, 4.51%), Vanguard group (628.3K shares, 3.49%), and Cvi (596.37K shares, 3.31%). Together, they hold 11.30% of INmune Bio’s total shares outstanding.

Does Blackrock own INmune Bio?

Yes, BlackRock owns 4.51% of INmune Bio, totaling 812.9K shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.17M$. In the last quarter, BlackRock increased its holdings by 572.73K shares, a 238.47% change.

Who is INmune Bio’s biggest shareholder by percentage of total assets invested?

Cvi is INmune Bio’s biggest shareholder by percentage of total assets invested, with 4.54% of its assets in 596.37K INmune Bio shares, valued at 5.26M$.

Who is the top mutual fund holder of INmune Bio shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of INmune Bio shares, with 1.96% of its total shares outstanding invested in 434.27K INmune Bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools